EN DE

The Procter & Gamble Company (PRG) Fair Value & Analysis

Consumer Defensive · DE · Market cap €301B · ISIN US7427181091

What is The Procter & Gamble Company really worth?

TP The Procter & Gamble Company PRG · XETRA
Price€126.26
Fair Value€94.82
Upside−24.9%
Quality74/100

A solid business, but trading 33% above our fair value of €94.82.

As of Sep 3, 2026, the fair value of The Procter & Gamble Company is €94.82 per share against a price of €126.26, so the fair value sits 25% below the price. A model estimate blended from multiple valuation models, recalculated regularly.

Watch The Procter & Gamble Company for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Strengths

Healthy Growth (revenue 5y +3.5 %/yr)
Solidly profitable · 19.2% net margin
Low debt · generates free cash flow
Ranks above peers (10/15)
Wide moat 79/100

Risks

!Weak on dividend: 27 out of 100

For context

·3.35% dividend yield
Evidence: High Range €62.05 – €129.14

Fair value as of: Sep 3, 2026

From 24 valuation models · updated 3 days ago

Fair value updated Sep 3, 2026, revised from €94.27 to €94.82 (+0.6%) since Aug 27, 2026. Share price +0.5% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • A high-quality business (quality 74/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • A fairly wide model range (€62.05 to €129.14) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

€164.79 €101.48 Fair Value €94.82 Jul 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 3, 2026.

How to read this chart

60‑month range €101.48 – €164.79 · fair‑value band €62.05 – €129.14 · the €126.26 price screens above the €94.82 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 3, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

The Procter & Gamble Company (PRG) currently trades at €126.26, while our model-based Fair Value estimate is €94.82, implying the stock looks roughly 33.2% overvalued today. The Quality Score stands at 74/100 (solid quality), in the Consumer Defensive sector. Bull case: the Multiples group reads highest at a median of €116.62 per share, and 2 of the 24 models we run sit above the €126.26 price. Bear case: the Asset-Based group reads lowest at €15.04, and 22 of the 24 models stay below the price. Evidence for this calculation is high.

Over the trailing twelve months, The Procter & Gamble Company generated revenue of €86.7B at a net margin of 19.2%. Revenue grew 7.4% year over year. It earns a return on equity of 31.1%. Net debt stands at €25.9B. Fundamentals as of Sep 3, 2026

Our scenario range runs from €62.05 (bear case) to €129.14 (bull case); at €126.26, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −36% fair-value upside, at −25%, PRG screens cheaper than that median.

Fair Value models

This estimate rests on fiscal year 2025 figures, and about 12 months have passed since. In that time the company retained roughly €1.64 per share, which is 1.7 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF best evidence €59.29 €87.68 €131.41 80
Growth DCF €61.84 €89.08 €129.29 78
Owner Earnings €64.01 €94.42 €141.28 76
All 24 models by family
DCF Models
FCF DCF best evidence €59.29 €87.68 €131.41 80
Owner Earnings €64.01 €94.42 €141.28 76
5Y Revenue Exit €39.62 €58.26 €81.32 73
5Y EBITDA Exit €71.50 €113.77 €161.73 75
5Y P/E Exit €77.39 €124.02 €171.17 71
10Y Revenue Exit €45.12 €63.08 €83.95 67
10Y EBITDA Exit €66.45 €101.04 €142.17 68
10Y P/E Exit €70.18 €108.05 €149.00 64
Earnings-Based
Graham-Dodd €46.65 €94.44 €118.88 66
EPV €63.58 €75.97 €86.98 74
Dividend Discount
Gordon GGM €40.78 €60.44 €81.76 68
DDM Multi-Stage €40.78 €58.66 €80.22 67
Multiples
P/E Multiple €108.04 €144.06 €180.07 63
P/S Multiple €43.43 €57.91 €72.39 58
P/B Multiple €87.46 €116.62 €145.77 55
EV/EBIT €105.35 €142.67 €180.00 66
EV/EBITDA €90.92 €123.44 €155.95 67
EV/Revenue €31.37 €47.66 €63.95 53
Asset-Based
NCAV (Graham) €11.23 €15.04 €22.45 54
Growth DCF
Growth DCF €61.84 €89.08 €129.29 78
Rev-Margin DCF €39.62 €59.33 €80.81 73
Economic Profit
Residual Income €43.97 €54.73 €242.48 64
ROIC Compounder €65.80 €81.66 €98.17 72
Growth Earnings
Growth-Adj P/E €78.55 €112.21 €145.87 67

Widest divergence: Multiples (€116.62) versus Asset-Based (€15.04). Highest evidence: FCF DCF (80).

Notify me when PRG reaches fair value

Put PRG on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 21.5 as of Jul 11, 2026
P/S ratio 4.07 P/E × margin
EPS (TTM) €6.01 price ÷ EPS = P/E 21.5
Dividend yield 3.3% payout 70.3%
Net margin 19.0% FY2025
Return on equity 31.1% TTM
More key figures
Profitability
Return on assets (EBIT) 15.4% avg 5y
Operating margin 23.1% TTM
Growth
Revenue (TTM) €86.7B TTM
Revenue growth (YoY) +7.4% 3y avg +1.7%
EPS growth (YoY) +5.8%
Balance sheet & cash flow
Free cash flow €14.0B FY2025
Net debt €25.9B FY2025 · ≈ 1.8 yrs of FCF

Figures from reported company fundamentals · as of Sep 3, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 74/100

Of which business quality 71 · Market factors (momentum, volatility) 52

Profitability 73
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 65
Earnings quality: real cash, not paper profit
Fin. Strength 70
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 93
Calm price path (market factor)
Momentum 36
Price trend over the last 3–12 months (market factor)
52W Momentum 34
Distance to the 52-week high (market factor)
Net Issuance 91
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.

Full company description

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

The Procter & Gamble Company reported revenue of $84.3B in FY2025 versus $76.1B in FY2021, a compound +2.6%/yr. Reported net income was $16.0B in FY2025, compounding +2.8%/yr from FY2021.

Growth Quality 75/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
€84.3B
Latest YoY
+0.3%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.7%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.5%
Avg. revenue growth/yr (39Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.4%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
+8.9% · in EUR
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share+5.6%
Dividend yield3.3%
Trend Two data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5Y 5.6% vs 10Y 5.8%, steady
Operating margin (EBIT) Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22.1% (2020) → 24.3% (2025) · rising
Worst earnings drop73% (2019) · in EUR
Revenue +2.6%/yr
FY21 $76.1B
FY22 $80.2B
FY23 $82.0B
FY24 $84.0B
FY25 $84.3B
Net income +2.8%/yr
FY21 $14.3B
FY22 $14.7B
FY23 $14.7B
FY24 $14.9B
FY25 $16.0B
Character of growth · EPS growth decomposed (2014-2025) +6.9 % p.a.
Revenue per share +3.7 %

of which total revenue +1.9 % · buybacks/dilution +1.7 %

EBIT margin +2.5 %
Tax rate +0.5 %
Residual (interest, one-offs) +0.1 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

PRG screens 33% overvalued. Compare with L'Oréal S.A →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "The Procter & Gamble Company Fair Value". https://www.fairvalue-calculator.com/stock/PRG.XETRA

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE62 · sector 58
FUTURE56 · sector 30
PAST71 · sector 27
HEALTH60 · sector 67
DIVIDEND27 · sector 47

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Sep 3, 2026).

Stock Price Fair Value vs Fair Value
L'Oréal S.A LORL C$24.76 C$22.64 −9%
Unilever PLC UNA €55.92 €40.47 −28%
Colgate-Palmolive Company CL $90.75 $55.28 −39%
500696 500696 ₹2,093 ₹641.55 −69%
Hindustan Unilever Limited HINDUNILVR ₹2,015 ₹789.46 −61%
Kenvue Inc KVUE $18.95 $10.97 −42%
Kimberly-Clark Corporation KMB $109.55 $79.71 −27%
Henkel AG HEN3 €76.42 €85.95 +12%
The Estée Lauder Companies Inc ESLA €86.54 €18.84 −78%
Church & Dwight Co CHD $101.26 $65.12 −36%

Compare The Procter & Gamble Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is The Procter & Gamble Company (PRG) overvalued or undervalued?
As of Sep 3, 2026, our model estimates a fair value of €94.82 versus a price of €126.26, about −25% upside (overvalued).
What is the fair value of PRG?
Our model-based fair value for The Procter & Gamble Company is €94.82 (as of Sep 3, 2026), built from audited fundamentals. The current price: €126.26.
What is the quality score of PRG?
The Procter & Gamble Company has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for The Procter & Gamble Company (PRG)?
Our model-based price target is the fair value of €94.82 (as of Sep 3, 2026) from 24 valuation models. Cautious scenario €62.05, optimistic scenario €129.14. It is a calculation from audited fundamentals, not an analyst target.
What is the The Procter & Gamble Company stock forecast for 2026?
Our models put fair value at €94.82, about −25% upside versus a price of €126.26 (overvalued). Cautious scenario €62.05, optimistic scenario €129.14. The calculation is refreshed regularly with new filings.
What is the revenue of The Procter & Gamble Company (PRG)?
The Procter & Gamble Company reported trailing-twelve-month revenue of about €86.7B (latest available figure, as of Sep 3, 2026).
What is the net profit margin of PRG?
The net profit margin of The Procter & Gamble Company is about 19.2%, meaning it keeps roughly 19.2% of revenue as net income. Based on the latest reported figures.
Does The Procter & Gamble Company pay a dividend?
The Procter & Gamble Company currently shows a dividend yield of about 3.35% relative to its recent price (as of Sep 3, 2026).
Free · no account needed

Watch The Procter & Gamble Company in the live analysis

One click puts The Procter & Gamble Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.